The Complete Guide to GLP-1 Weight Loss

What Are GLP-1 Medications?

GLP-1 receptor agonists are a class of prescription medications originally developed to treat type 2 diabetes. GLP-1 stands for glucagon-like peptide-1, a naturally occurring hormone in your body that plays a key role in regulating blood sugar and appetite.

In recent years, several GLP-1 medications have been approved by the FDA specifically for chronic weight management. These medications have shown significant results in clinical trials, making them one of the most effective pharmaceutical options for weight loss available today.

How They Work

GLP-1 medications work by mimicking the natural GLP-1 hormone in your body. They act on multiple systems to support weight loss:

Appetite reduction: They act on receptors in the brain that regulate hunger, helping you feel full sooner and reducing cravings.
Slower gastric emptying: They slow the rate at which food leaves your stomach, which helps you feel satisfied for longer after meals.
Blood sugar regulation: They stimulate insulin release when blood sugar is elevated and reduce glucagon secretion, helping to stabilize glucose levels.

Who Qualifies

GLP-1 medications for weight loss are typically prescribed to adults who meet certain criteria. While each provider may have slightly different requirements, general guidelines include:

A body mass index (BMI) of 30 or greater (obesity).
A BMI of 27 or greater (overweight) with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol.
A history of unsuccessful weight loss attempts through diet and exercise alone.

Your healthcare provider will evaluate your full medical history to determine if a GLP-1 medication is appropriate for you. These medications are not recommended for everyone and have contraindications that must be considered.

Available Medications

Several GLP-1 medications are currently available in the United States. The most commonly prescribed options for weight loss include semaglutide (branded as Ozempic, Wegovy, and Rybelsus) and tirzepatide (branded as Mounjaro and Zepbound).

In addition to FDA-approved branded products, some providers offer compounded versions of semaglutide and tirzepatide through 503A or 503B pharmacies. Compounded medications are not FDA-approved and carry additional risks that should be discussed with your provider.

For detailed information about each medication, including dosing, pricing, and side effects, visit our medications page.

Expected Results

Clinical trials have shown that GLP-1 medications can lead to significant weight loss when combined with a reduced-calorie diet and increased physical activity. Results vary by medication and individual, but here is a general overview:

Most patients begin to see weight loss within the first 4 to 8 weeks of treatment.
On average, patients on semaglutide lost approximately 15% of their body weight over 68 weeks in clinical studies.
Tirzepatide showed average weight loss of approximately 20% of body weight in some clinical trials.
Weight loss tends to plateau after 12 to 18 months on treatment.

Individual results vary. Weight loss depends on factors including your starting weight, dosage, diet, exercise habits, and overall health. Some patients may regain weight after discontinuing the medication.

Side Effects

Like all prescription medications, GLP-1 receptor agonists can cause side effects. The most common side effects are gastrointestinal and tend to be mild to moderate, especially during the initial dose titration period:

Nausea (the most commonly reported side effect)
Vomiting
Diarrhea
Constipation
Abdominal pain
Decreased appetite

Most side effects improve over time as your body adjusts to the medication. Gradual dose titration (starting low and increasing slowly) is the standard approach used to minimize these effects. Talk to your doctor if side effects are severe or persistent.

Cost Overview

GLP-1 medications can be expensive, particularly without insurance coverage. Retail costs for branded medications range from approximately $1,000 to $1,300 per month. However, several options can help reduce costs:

Manufacturer savings programs: Novo Nordisk and Eli Lilly both offer savings cards that can reduce costs significantly for eligible patients.
Insurance coverage: Some plans cover GLP-1 medications, particularly when prescribed for type 2 diabetes.
Compounded alternatives: Some patients choose compounded versions, which typically cost between $200 and $250 per month. These are not FDA-approved.

For a detailed breakdown of all pricing options, visit our cost guide.

Finding a Provider

Getting started with a GLP-1 medication begins with finding a qualified healthcare provider. You can see a primary care physician, endocrinologist, weight management specialist, or a telehealth provider who prescribes GLP-1 medications.

When choosing a provider, consider factors such as their experience with GLP-1 medications, pricing transparency, accepted insurance plans, patient reviews, and whether they offer in-person or telehealth visits.

Our directory features over 3,600 verified providers across the United States. Browse providers near you to compare clinics and find the right fit for your needs.